ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
E00-E89: Endocrine, nutritional and metabolic diseases |
Autoimmune diabetes |
E08-E13 |
TLR2 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Atopic dermatitis |
L00-L99 |
CNR2; TRPV1 |
A00-B99: Certain infectious and parasitic diseases |
Postherpetic neuralgia |
B02.2, G44.847, G53.0 |
CNR1; TRPV1 |
C00-D49: Neoplasms |
Solid tumours |
C00-D48 |
TLR2 |
G00-G99: Diseases of the nervous system G00-G99 |
Spinal muscular atrophy |
G00-G99 |
SMN1;SMN2 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
CNR2 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Musculoskeletal pain |
R52, G89 |
TRPV1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Schizophrenia |
F20 |
CNR1 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Radiation sickness |
T66 |
TLR2 |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
TLR2 |
I00-I99: Diseases of the circulatory system |
Hypertension |
I10-I16 |
CNR1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Hyperlipidaemia |
E78 |
PPARD |
C00-D49: Neoplasms |
Prostate cancer |
C61 |
TLR2 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Psychotic disorders |
F20-F29 |
CNR1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic neuropathy |
E11.40 |
TRPV1 |
G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
CNR1; TRPA1; CNR2; TRPV1; TRPV1 |
C00-D49: Neoplasms |
Pancreatic cancer |
C25 |
TLR2 |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure |
Diagnostic test to differentiate primary and secondary hypothyroidism |
W88 |
TSHR |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Drug abuse |
F10-F19 |
CNR1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Osteoporosis |
M80-M81, Z79.890 |
CNR2 |
C00-D49: Neoplasms |
Ovarian cancer |
C56 |
CNR1 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Chronic pathological pain |
R52, G89 |
TRPV1 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Cough |
R05 |
TRPV1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Endocrine disease |
E00-E35 |
CNR1 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Chemotherapy-induced nausea |
R11 |
CNR1 |
G00-G99: Diseases of the nervous system G00-G99 |
Central nervous system disease |
G00-G99 |
CNR1; PPARD |
I00-I99: Diseases of the circulatory system |
Cerebrovascular ischaemia |
I61-I63 |
CNR1 |
NA: NA |
Esophagus sensitivity |
NA |
TRPV1 |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
CNR2 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Insomnia |
F51.0, G47.0 |
CNR1 |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
TRPV1 |
K00-K95: Diseases of the digestive system |
Non-alcoholic fatty liver disease |
K76.0 |
PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
CNR1; CNR1; CNR1; CNR1; CNR1; CNR1; PPARD; PPARD |
K00-K95: Diseases of the digestive system |
Gastroesophageal reflux disease |
K21 |
TRPV1 |
C00-D49: Neoplasms |
Melanoma |
C43 |
TLR2 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Nicotine dependence |
F17 |
CNR1 |
G00-G99: Diseases of the nervous system G00-G99 |
Acute migraine |
G43 |
TRPV1 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Acute or chronic pain |
R52, G89 |
TRPV1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Dyslipidaemias |
E78 |
PPARD; PPARD |
NA: NA |
Dyslipidemia |
NA |
PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
CNR1; CNR1 |
C00-D49: Neoplasms |
Overactive bladder disorder |
C67, N32.81 |
TRPV1; TRPV1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
CNR1; CNR1; CNR1 |
C00-D49: Neoplasms |
Myelodysplastic syndrome |
D46 |
TLR2 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anorexia |
F50.0-F50.1 |
CNR1 |
N00-N99: Diseases of the genitourinary system |
Urinary incontinence |
N39.3, N39.4, R32 |
TRPV1 |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism |
Immune disorder |
D80-D89 |
CNR2 |
K00-K95: Diseases of the digestive system |
Inflammatory bowel disease |
K50, K51 |
CNR2 |
C00-D49: Neoplasms |
Thyroid cancer diagnosis |
C73 |
TSHR |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 1 diabetes |
E10 |
PPARD |
I00-I99: Diseases of the circulatory system |
Ischemia |
I99.8 |
CNR1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Lipid metabolism disorder |
E75-E78 |
CNR1 |
G00-G99: Diseases of the nervous system G00-G99 |
Neuropathic pain |
G64, G90.0 |
CNR1; CNR2; TRPV1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
CNR1; PPARD |
I00-I99: Diseases of the circulatory system |
Atherosclerosis |
I70 |
PPARD |
C00-D49: Neoplasms |
Thyroid cancer |
C73 |
TSHR |
J00-J99: Diseases of the respiratory system |
Throat irritation |
J39.2 |
TRPA1 |